Basel, Basel, Switzerland
Karl Burgin is a life sciences professional with over 30 years experience in biomedical research and product development. Having lived and worked in five countries on three continents, Karl brings a truly global perspective to the challenges of product development. Specialties: Drug Regulatory Affairs, Product Development, Organizational Change Management
Maxia Strategies, LLC is a life sciences product development consultancy specializing in regulatory strategies and services to maximize the value of drugs, diagnostics and medical devices throughout their lifecycle.
Led multifunctional team to develop a comprehensive strategy to streamline drug development within Asia, and to integrate within the global development strategy
Maintained optimal communication and interaction between the drug development organizations of Roche and Chugai pharmaceuticals, and facilitated all drug development activities in Japan for products licensed from Roche to Chugai.